No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological / adverse effects*
-
Humans
-
Male
-
Middle Aged
-
Myasthenia Gravis / etiology*
-
Myasthenia Gravis / pathology
-
Myositis / etiology*
-
Myositis / pathology
-
Nivolumab / adverse effects*
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab